Adiposs

AdipoPharma SAS

This biotech company develops a therapeutic peptide to treat insulin resistance and type 2 diabetes for patients with metabolic diseases.

AdipoSeeds

This biotech company develops adipose-derived mesenchymal stem cell platelets for regenerative medicine treatments and blood transfusion substitutes to assist healthcare providers and patients.

AdipoPharma

This clinical-stage biotechnology company develops therapeutic peptides to treat insulin resistance and type 2 diabetes for patients with metabolic disorders.

Alzeca Biosciences

This company develops MRI contrast agents to enable early diagnosis of Alzheimer's disease and other neurodegenerative disorders for healthcare providers and clinical researchers.

Adialante

Adialante develops mobile magnetic resonance imaging systems for medical clinics to enable accessible cancer screening.

Inventerapharm

This company develops diagnostic imaging contrast agents for healthcare providers and patients with biliary or pancreatic conditions.

Abscint

The company develops radiolabelled single-domain antibodies for molecular imaging diagnostics to help oncologists and nuclear medicine physicians select and monitor cancer treatments.

Adcytherix

This biopharmaceutical company develops novel antibody-drug conjugates to treat various forms of cancer for patients with high unmet clinical needs.